Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Allergan Plc (AGN)

Allergan Plc (AGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 60,274,940
  • Shares Outstanding, K 328,277
  • Annual Sales, $ 15,787 M
  • Annual Income, $ -5,096,400 K
  • 60-Month Beta 1.66
  • Price/Sales 3.79
  • Price/Cash Flow 4.93
  • Price/Book 1.00

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 4.49
  • Number of Estimates 7
  • High Estimate 4.96
  • Low Estimate 4.29
  • Prior Year 4.29
  • Growth Rate Est. (year over year) +4.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
170.06 +7.97%
on 10/16/19
183.79 -0.10%
on 11/12/19
+13.45 (+7.90%)
since 10/15/19
3-Month
156.75 +17.14%
on 08/16/19
183.79 -0.10%
on 11/12/19
+27.27 (+17.44%)
since 08/15/19
52-Week
114.27 +60.68%
on 06/17/19
183.79 -0.10%
on 11/12/19
+24.24 (+15.21%)
since 11/15/18

Most Recent Stories

More News
Aesthetic Devices Market Analysis, Size, Share, Trends, Key players, Drivers and Forecast with latest research report and Growth by 2025

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Allergan...

MMM : 171.88 (+0.56%)
AGN : 183.61 (+0.62%)
CYNO : 66.15 (+0.23%)
NSRGY : 105.2750 (+0.49%)
SIEN : 8.07 (-5.39%)
ELOS : 11.00 (unch)
VRX.TO : 30.80 (-3.33%)
ZLTQ : 56.48 (unch)
ZBH : 146.78 (+1.21%)
Exicure and Allergan Enter Into Collaboration, Option and License Agreement to Discover and Develop SNA-based Treatments for Hair Loss Disorders

--- Exicure to Host Conference Call Today at 8:30am ET/7:30am CT

XCUR : 2.47 (-9.85%)
AGN : 183.61 (+0.62%)
Editas (EDIT) Beats on Q3 Earnings, Amends Celgene Deal

Editas' (EDIT) portfolio currently lacks an approved product. The focus of third-quarter earnings call was on its pipeline development.

AGN : 183.61 (+0.62%)
CELG : 110.02 (unch)
EDIT : 22.86 (+0.88%)
CRSP : 56.87 (+3.29%)
The Zacks Analyst Blog Highlights: Booking, Allergan, Honda Motor, Infosys and Activision Blizzard

The Zacks Analyst Blog Highlights: Booking, Allergan, Honda Motor, Infosys and Activision Blizzard

AGN : 183.61 (+0.62%)
HMC : 29.00 (+0.55%)
INFY : 9.86 (-0.10%)
ATVI : 53.44 (+1.40%)
BKNG : 1,848.82 (-0.90%)
At CAGR 2.5% Inflammatory Bowel Disease Treatment Market 2019 Growing Globally, Industry Size, Share Leaders, Current Trends, Status by Major Key Vendors, and Drivers by Forecast To 2023

ABBV : 88.63 (+1.14%)
AGN : 183.61 (+0.62%)
NVS : 90.04 (+0.59%)
PFE : 37.28 (+2.00%)
TKPYY : 16.5900 (-0.90%)
VRX.TO : 30.80 (-3.33%)
World Dry Eye Medication Market Report 2020: Major Players are Novartis, Allergan, Otsuka, Santen Pharmaceutical and Auven Therapeutics - ResearchAndMarkets.com

The "Dry Eye Medication Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering.

AGN : 183.61 (+0.62%)
NVS : 90.04 (+0.59%)
AbbVie Prices $30 Billion of Senior Unsecured Notes

AbbVie Inc. (NYSE:ABBV) ("AbbVie") announced today that it has priced its previously announced private offering (the "Offering") of senior unsecured notes in a combined aggregate principal amount of $30...

AGN : 183.61 (+0.62%)
ABBV : 88.63 (+1.14%)
Top Stock Reports for Booking Holdings, Allergan & Honda Motor Co.

Top Stock Reports for Booking Holdings, Allergan & Honda Motor Co.

INFY : 9.86 (-0.10%)
HMC : 29.00 (+0.55%)
BKNG : 1,848.82 (-0.90%)
BCE : 48.50 (+0.17%)
ATVI : 53.44 (+1.40%)
AGN : 183.61 (+0.62%)
Allergan Plc Set to Possibly Pullback After Yesterday's Rally of 7.61%

Allergan Plc (NYSE:AGN) traded in a range yesterday that spanned from a low of $180.70 to a high of $181.91. Yesterday, the shares gained 7.6%, which took the trading range above the 3-day high of $181.62...

AGN : 183.61 (+0.62%)
Speed Study Start-Up: People, Process, and Technology Pillars, Upcoming Webinar Hosted by Xtalks

The quality of study start-up can dictate the success of a clinical study. With increasing site activation cycle times, extended contract negotiations and 80 percent of organizations still using spreadsheets...

AGN : 183.61 (+0.62%)
VEEV : 153.16 (+3.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade AGN with:

Business Summary

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan...

See More

Key Turning Points

2nd Resistance Point 184.64
1st Resistance Point 184.12
Last Price 183.61
1st Support Level 182.74
2nd Support Level 181.88

See More

52-Week High 183.79
Last Price 183.61
Fibonacci 61.8% 157.23
Fibonacci 50% 149.03
Fibonacci 38.2% 140.83
52-Week Low 114.27

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar